A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Status:
COMPLETED
Trial end date:
2025-02-22
Target enrollment:
Participant gender:
Summary
This study will look at how well the new medicine CagriSema helps people with excess body weight losing weight compared to a "dummy" medicine and a medicine called semaglutide. Participants will either get CagriSema, a dummy medicine or semaglutide. Which treatment participants get is decided by chance. Participants will take one injection once a week. The study medicine will be injected briefly with a thin needle, typically in the stomach, thighs or upper arms. The study will last for about 1 year.